-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R1NiuHfrlqc4Xrw5xIeet3UoWUrfRNNFPidWsc+LxOaXWJ4nOWpWgpr0VioJPllV ykiQ2Zem8LISfwkrKGwZDA== 0000950142-04-000285.txt : 20040202 0000950142-04-000285.hdr.sgml : 20040202 20040202152902 ACCESSION NUMBER: 0000950142-04-000285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040129 FILED AS OF DATE: 20040202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS SOROS PARTNERS LLC CENTRAL INDEX KEY: 0001250191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559108 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 29TH FL CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS BIOTECH FUND PARTNERS LLC CENTRAL INDEX KEY: 0001250198 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559107 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SFM PARTICIPATION LP CENTRAL INDEX KEY: 0001253598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559103 MAIL ADDRESS: STREET 1: C/O SOROS FUND MANAGEMENT LLC STREET 2: 888 SEVENTH AVE 31ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS EC LLC CENTRAL INDEX KEY: 0001253319 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559106 BUSINESS ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUSPUR LLC CENTRAL INDEX KEY: 0001253323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559105 BUSINESS ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS SOROS BIOPHARMACEUTICAL FUND LP CENTRAL INDEX KEY: 0001111408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559109 BUSINESS ADDRESS: STREET 1: ARMY & NAVY CLUB BLDG STREET 2: 1627 I ST NW STE 610 CITY: WASHINGTON STATE: DC ZIP: 20006 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 29TH FL CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SFM AH LLC CENTRAL INDEX KEY: 0001237655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559101 BUSINESS ADDRESS: STREET 1: C/O SOROS FUND MANAGEMENT LLC STREET 2: 888 SEVENTH AVENUE 31ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2122626300 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VALENTIS INC CENTRAL INDEX KEY: 0000932352 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943156660 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 863A MITTEN RD CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6506971900 MAIL ADDRESS: STREET 1: 863A MITTEN ROAD CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: MEGABIOS CORP DATE OF NAME CHANGE: 19960716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS GEORGE CENTRAL INDEX KEY: 0000900203 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559102 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-262--6 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 33RD FLR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEARL FRANK H CENTRAL INDEX KEY: 0000927752 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559104 BUSINESS ADDRESS: STREET 1: 2099 PENNSYLVANIA AVENUE NW STREET 2: SUITE 900 CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: 2024520101 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVENUE NW STREET 2: SUITE 900 CITY: WASHINGTON STATE: DC ZIP: 20003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS FUND MANAGEMENT LLC CENTRAL INDEX KEY: 0001029160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22987 FILM NUMBER: 04559110 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2128721054 MAIL ADDRESS: STREET 1: C/O AKIN, GUMP, STRAUSS,HAUER,FELD, STREET 2: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 form4-valentis_012904ex.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP X0201 4 2004-01-29 0 0000932352 VALENTIS INC VLTS 0001111408 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP 888 SEVENTH AVENUE 29TH FLOOR NEW YORK NY 10106 0 0 1 0 0001250191 PERSEUS SOROS PARTNERS LLC 2099 PENNSYLVANIA AVENUE SUITE 900 WASHINGTON DC 20006-1813 0 0 1 0 0001250198 PERSEUS BIOTECH FUND PARTNERS LLC 2099 PENNSYLVANIA AVENUE SUITE 900 WASHINGTON DC 20006-1813 0 0 1 0 0001253319 PERSEUS EC LLC 2099 PENNSYLVANIA AVENUE SUITE 900 WASHINGTON DC 20006-1813 0 0 1 0 0001253323 PERSEUSPUR LLC 2099 PENNSYLVANIA AVENUE SUITE 900 WASHINGTON DC 20006-1813 0 0 1 0 0000927752 PEARL FRANK H 2099 PENNSYLVANIA AVENUE SUITE 900 WASHINGTON DC 20006-1813 0 0 1 0 0001253598 SFM PARTICIPATION LP 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 0 0000900203 SOROS GEORGE 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 0 0001237655 SFM AH LLC 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 0 0001029160 SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 0 Common Stock, $.001 par value 2004-01-29 4 P 0 266972 2.05 A 2167744 D Common Stock Purchase Warrant (right to buy) 3.00 2004-01-29 4 P 0 106788 0.00 A 2004-01-29 2009-01-29 Common Stock 106788 106788 D Perseus-Soros BioPharmaceutical Fund, L.P. ("Perseus-Soros") acquired a Common Stock Purchase Warrant (the "Warrant") to acquire 106,788 shares of Common Stock. The aggregate purchase price of the Common Stock purchased as reported in Table I and the Warrant was $547,293. The Common Stock underlying the Warrant may be purchased at a price per share equal to $3.00 (the "Exercise Price"). The Exercise Price and the number of shares issuable upon exercise of the Warrant will be subject to adjustment upon the occurrence of certain events as set forth in the Warrant. Further, exercise of the Warrant may be restricted based on the number of securities the holder thereof would be deemed to beneficially own upon exercise thereof. The Warrant is exercisable at any time, from the date of issuance until the five year anniversary thereof (the "Expiration Date"). At the Expiration Date, the Warrant may be automatically exercised on a "cashless exercise" basis if the market price on such date is greater than 102% of the Exercise Price. In the event that the volume-weighted market price of the Common Stock exceeds $5.00 for thirty consecutive trading days, the Company may require exercise of the Warrant. The Warrant is in addition to the warrant to acquire 195,122 shares of Common Stock (with identical terms, other than the expiration date, which was December 31, 2008) which was reported by Perseus-Soros and the other filing persons on a Form 4 filed on January 5, 2004. All of the securities reported herein are held for the account of Perseus-Soros. Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseus EC, L.L.C., a Delaware limited liability company ("Perseus EC"), is the managing member of Perseus Partners. Perseuspur, LLC, a Delaware limited liability company ("Perseuspur"), is a member of Perseus EC. Mr. Frank H. Pearl ("Mr. Pearl") is the sole member of Perseuspur. SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. The sole managing member of SFM AH is Soros Fund Management LLC, a Delaware limited liability company ("SFM LLC"). Mr. George Soros serves as Chairman of SFM LLC. (5) Mr. Brown is signing in his capacity as Ass't General Counsel of Soros Fund Management LLC,as Managing Member of SFM AH LLC, as General Partner of SFM Participation,L.P., as Managing Member of Perseus-Soros Partners, LLC, as General Partner of Perseus-Soros Biopharmaceutical Fund, L.P. (6) Mr.Brown is signing in his capacity as Ass't General Counsel of Soros Fund Management LLC,as Managing Member of SFM AH LLC,as General Partner of SFM Participation,L.P.,as Managing Member of Perseus-Soros Partners,LLC. (7) Mr.Brown is signing in his capacity as Ass't General Counsel of Soros Fund Management LLC,as Managing Member of SFM AH LLC,as General Partner of SFM Participation,L.P. (8) Mr.Brown is signing in his capacity as Ass't General Counsel of Soros Fund Management LLC,as Managing Member of SFM AH LLC. Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934,as amended (the "Act"),Perseus-Soros Partners,Perseus Partners,SFM Participation,Perseus EC,Persuspur,Mr.Pearl,SFM AH, Mr. Soros and SFM LLC are deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of Perseus-Soros. Pursuant to Rule 16a-1(a)(4) under the Act,this filing shall not be deemed an admission that Perseus-Soros Partners,Perseus Partners,SFM Participation,Perseus EC,Persuspur, Mr.Pearl,SFM AH,Mr.Soros or SFM LLC is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros in excess of such amount. John F. Brown, Perseus-Soros BioPharmaceutical Fund, L.P. (5) 2004-02-02 John F. Brown, Perseus-Soros Partners, LLC (6) 2004-02-02 Rodd Macklin, Secretary and Treasurer, Perseus Biotech Fund Partners, LLC 2004-02-02 Rodd Macklin, Secretary and Treasurer, Perseus EC, L.L.C. 2004-02-02 Rodd Macklin, Secretary and Treasurer, Perseuspur, LLC 2004-02-02 Rodd Macklin, Attorney-in-Fact, Mr. Frank H. Pearl 2004-02-02 John F. Brown, SFM Participation, L.P. (7) 2004-02-02 John F. Brown, SFM AH LLC (8) 2004-02-02 John F. Brown, Attorney-in-Fact, Mr. George Soros 2004-02-02 John F. Brown, Assistant General Counsel, Soros Fund Management LLC 2004-02-02 -----END PRIVACY-ENHANCED MESSAGE-----